Suppr超能文献

一种针对蛋白酶裂解位点的新型HIV疫苗。

A novel HIV vaccine targeting the protease cleavage sites.

作者信息

Li Hongzhao, Omange Robert W, Plummer Francis A, Luo Ma

机构信息

Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

出版信息

AIDS Res Ther. 2017 Sep 12;14(1):51. doi: 10.1186/s12981-017-0174-7.

Abstract

HIV preferentially infects activated CD4+ T cells and mutates rapidly. The classical vaccine approach aimed to generate broad immune responses to full HIV proteins largely failed to address the potential adverse impact of increased number of activated CD4+ T cells as viral targets. Learning from natural immunity observed in a group of HIV resistant Kenyan female sex workers, we are testing a novel vaccine approach. It focuses immune response to the highly conserved sequences surrounding the HIV protease cleavage sites (PCS) to disrupt viral maturation, while limiting excessive immune activation. Our pilot studies using nonhuman primate SIV infection models suggest that this approach is feasible and promising.

摘要

人类免疫缺陷病毒(HIV)优先感染活化的CD4+ T细胞,且变异迅速。经典的疫苗研发方法旨在对完整的HIV蛋白产生广泛的免疫反应,但在很大程度上未能解决作为病毒靶标的活化CD4+ T细胞数量增加所带来的潜在不利影响。通过研究一组对HIV具有抗性的肯尼亚女性性工作者的天然免疫情况,我们正在测试一种新型疫苗研发方法。该方法将免疫反应聚焦于HIV蛋白酶切割位点(PCS)周围的高度保守序列,以破坏病毒成熟,同时限制过度的免疫激活。我们使用非人灵长类动物猴免疫缺陷病毒(SIV)感染模型进行的初步研究表明,这种方法是可行且有前景的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b1/5594498/11ea993fbede/12981_2017_174_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验